President Donald Trump declared a “shock to the system” as he unveiled historic prescription drug price cuts that promise to reshape healthcare across the nation. Partnering with Pfizer, Trump announced that Medicaid programs will now access medications at the same low prices offered to the world’s richest nations — a move that slashes costs for millions of Americans. Drugs like Eucrisa, Xeljanz, and Zavzpret will drop by up to 80 percent, marking one of the boldest consumer victories in U.S. medical history.
Trump called it “fairness long overdue,” insisting that Americans will no longer subsidize inflated global prices. With midterms approaching and his approval rating surging to 53 percent, he framed the move as both moral and economic justice. “This is not just policy,” he said. “It’s people’s lives.” For many voters, these savings may soon feel like the clearest sign yet — Trump’s comeback is already underway.
